Gene Synthesis Software Market
Gene Synthesis Software Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Gene Synthesis Software Market Size and Growth
The Gene Synthesis Software market is experiencing robust growth, driven by increasing demand for genetic engineering and personalized medicine. The market size was valued at approximately $400 million in 2023, with a projected CAGR of 11% through 2030. Advancements in bioinformatics and automation are enhancing operational efficiency and accessibility.
Companies Covered
(Covid 19 Impact Covered)
◍ Eurofins Genomics
◍ ATUM
◍ Biotage
◍ Bioneer Corporation
◍ Eurogentec
◍ GenScript
◍ GENEWIZ
◍ Integrated DNA Technologies
◍ OriGene Technologies
◍ Thermo Fisher Scientific
◍ Bio Basic
◍ Twist Bioscience
◍ BioCat GmbH
◍ ProteoGenix
◍ Charles River
◍ Biosearch Technologies
◍ Beijing SBS Genetech
◍ Eton Bioscience
The Gene Synthesis Software Market sees players like Eurofins Genomics, GenScript, and Thermo Fisher Scientific leveraging software for enhanced design and efficiency. Companies provide tailored solutions to optimize synthesis, thereby expanding market scope. Sales revenues include:
- GenScript: approx. $100 million
- Eurofins: approx. $450 million
- Twist Bioscience: approx. $80 million. Request Sample Report
Market Segmentation
By Application
◍ Academic and Research Institutes
◍ Biotech and Pharmaceutical
◍ Diagnostic Laboratories
◍ Others
By Product
◍ Solid Phase Synthesis
◍ Chip-based DNA Synthesis
◍ PCR-based Enzyme Synthesis
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
